Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongkun Wang

Showing results (111-120 of 164) with videos related to

Pageof 17
Sort By:
Journal of Pancreatic Cancer|May 9, 2019
A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal AdenocarcinomaAnteneh A Tesfaye, Hongkun Wang, Marion L Hartley, et al.
Nature Communications|July 31, 2020
Molecular mechanisms underlying menthol binding and activation of TRPM8 ion channelLizhen Xu, Yalan Han, Xiaoying Chen, et al.
Clinical and Translational Medicine|February 20, 2022
Hyperactivation of platelet-derived growth factor signalling contributes to arrhythmogenesis in Brugada syndromeHongkun Wang, Lizhen Xu, Shuai Han, et al.
Clinical Trials (London, England)|July 3, 2010
Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trialsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Cancer Medicine|February 27, 2021
A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignanciesNeel D Trivedi, Samantha Armstrong, Hongkun Wang, et al.
Journal of Bronchology & Interventional Pulmonology|December 24, 2025
Outcomes From Expanded Qualification Parameters for Bronchoscopic Lung Volume Reduction (BLVR)Amit K Mahajan, Priya P Patel, Duy K Duong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic CancerMichael J Pishvaian, Hongkun Wang, Aiwu Ruth He, et al.
Clinical and Translational Medicine|August 18, 2025
Reversing cardiac hypertrophy and heart failure using a cardiac targeting peptide linked to miRNA106aMing Lu, Siqi Cai, Kyle Korolowicz, et al.
Respiratory Medicine|June 9, 2026
Comparative Outcomes Based on Pre-Bronchoscopic Lung Volume Reduction (BLVR) Six-Minute Walk Distance (6MWD)Amit K Mahajan, Priya P Patel, Duy K Duong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology GroupsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Pageof 17

Showing results (111-120 of 164) with videos related to

Sort By:
Pageof 17
Journal of Pancreatic Cancer|May 9, 2019
A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal AdenocarcinomaAnteneh A Tesfaye, Hongkun Wang, Marion L Hartley, et al.
Nature Communications|July 31, 2020
Molecular mechanisms underlying menthol binding and activation of TRPM8 ion channelLizhen Xu, Yalan Han, Xiaoying Chen, et al.
Clinical and Translational Medicine|February 20, 2022
Hyperactivation of platelet-derived growth factor signalling contributes to arrhythmogenesis in Brugada syndromeHongkun Wang, Lizhen Xu, Shuai Han, et al.
Clinical Trials (London, England)|July 3, 2010
Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trialsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Cancer Medicine|February 27, 2021
A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignanciesNeel D Trivedi, Samantha Armstrong, Hongkun Wang, et al.
Journal of Bronchology & Interventional Pulmonology|December 24, 2025
Outcomes From Expanded Qualification Parameters for Bronchoscopic Lung Volume Reduction (BLVR)Amit K Mahajan, Priya P Patel, Duy K Duong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic CancerMichael J Pishvaian, Hongkun Wang, Aiwu Ruth He, et al.
Clinical and Translational Medicine|August 18, 2025
Reversing cardiac hypertrophy and heart failure using a cardiac targeting peptide linked to miRNA106aMing Lu, Siqi Cai, Kyle Korolowicz, et al.
Respiratory Medicine|June 9, 2026
Comparative Outcomes Based on Pre-Bronchoscopic Lung Volume Reduction (BLVR) Six-Minute Walk Distance (6MWD)Amit K Mahajan, Priya P Patel, Duy K Duong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology GroupsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Pageof 17